.After F2G's first effort to receive a new course of antifungal to market was actually wrecked by th...
.Moderna has actually sworn to cut R&D costs through $1.1 billion by 2027. The decision to shrink...
.Merely four months after Sanofi bet $80 million in beforehand cash on Key Rehabs' losmapimod, the p...
.Cancer firm Oncternal Therapeutics is actually folding all its own professional tests and also givi...
.Roche is actually keeping out chances that its own injectable obesity prospect could at some point ...
.Novo Nordisk has actually elevated the lid on a period 1 trial of its oral amylin and GLP-1 recepto...
.Simply a couple of brief full weeks after winning an FDA Fast lane tag for its own investigational ...
.Not long after a favorable information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based...
.BridgeBio Pharma is lowering its own genetics treatment spending plan as well as pulling back from ...
.GSK's attempt to create the first vaccine for herpes simplex infection (HSV) has finished in failin...